BidaskClub Upgrades Acadia Healthcare (NASDAQ:ACHC) to Sell

Acadia Healthcare (NASDAQ:ACHC) was upgraded by research analysts at BidaskClub from a “strong sell” rating to a “sell” rating in a note issued to investors on Wednesday, BidAskClub reports.

A number of other research firms have also recently issued reports on ACHC. TheStreet upgraded Acadia Healthcare from a “d+” rating to a “c” rating in a research report on Monday, June 17th. Mizuho set a $30.00 price objective on Acadia Healthcare and gave the company a “hold” rating in a research report on Friday, May 31st. Zacks Investment Research cut Acadia Healthcare from a “hold” rating to a “sell” rating and set a $31.00 price objective on the stock. in a research report on Wednesday, August 7th. Raymond James cut Acadia Healthcare from a “strong-buy” rating to an “outperform” rating and set a $45.00 price objective on the stock. in a research report on Wednesday, July 31st. Finally, UBS Group lowered their price objective on Acadia Healthcare from $30.00 to $29.00 and set a “neutral” rating on the stock in a research report on Friday, September 6th. Three investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have assigned a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus price target of $36.00.

Shares of NASDAQ ACHC opened at $31.58 on Wednesday. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 1.53. The business’s 50 day moving average is $28.50 and its two-hundred day moving average is $30.94. The company has a market cap of $2.56 billion, a P/E ratio of 14.10, a P/E/G ratio of 1.28 and a beta of 0.71. Acadia Healthcare has a 12 month low of $24.27 and a 12 month high of $45.35.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings data on Tuesday, July 30th. The company reported $0.61 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.59 by $0.02. The business had revenue of $789.00 million for the quarter, compared to analysts’ expectations of $795.31 million. Acadia Healthcare had a positive return on equity of 7.20% and a negative net margin of 6.80%. Acadia Healthcare’s quarterly revenue was up 3.0% on a year-over-year basis. During the same period in the previous year, the business posted $0.70 earnings per share. Sell-side analysts expect that Acadia Healthcare will post 2.14 earnings per share for the current fiscal year.

In related news, CEO Debra K. Osteen purchased 20,000 shares of the stock in a transaction on Thursday, September 5th. The shares were purchased at an average cost of $26.53 per share, for a total transaction of $530,600.00. Following the completion of the transaction, the chief executive officer now directly owns 117,178 shares of the company’s stock, valued at approximately $3,108,732.34. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Corporate insiders own 2.60% of the company’s stock.

Large investors have recently made changes to their positions in the business. Clearbridge Investments LLC bought a new stake in Acadia Healthcare in the first quarter valued at $12,709,000. Virginia Retirement Systems ET AL grew its position in Acadia Healthcare by 2.5% in the second quarter. Virginia Retirement Systems ET AL now owns 16,300 shares of the company’s stock valued at $570,000 after acquiring an additional 400 shares during the period. TCW Group Inc. grew its position in Acadia Healthcare by 17.9% in the first quarter. TCW Group Inc. now owns 65,319 shares of the company’s stock valued at $1,914,000 after acquiring an additional 9,917 shares during the period. Dynamic Technology Lab Private Ltd bought a new stake in Acadia Healthcare in the first quarter valued at $513,000. Finally, Neuberger Berman Group LLC grew its position in Acadia Healthcare by 89.3% in the first quarter. Neuberger Berman Group LLC now owns 1,658,751 shares of the company’s stock valued at $48,620,000 after acquiring an additional 782,480 shares during the period.

About Acadia Healthcare

Acadia Healthcare Company, Inc develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities in the United States, the United Kingdom, and Puerto Rico.

Recommended Story: What is total return in investing?

Analyst Recommendations for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.